Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26077215 | 1.00 | POLB (0.46) | POLBSMN1; SMN2ALDH1A1TSHRHDAC6 | |
| SCHEMBL15952948 | 0.98 | ALDH1A1 (0.44) | POLBSMN1; SMN2ALDH1A1TSHRHDAC6 | |
| SCHEMBL15038306 | 0.78 | HDAC3 (0.51) | ALDH1A1TSHRHDAC6USP2TDP1 | |
| SCHEMBL10413396 | 0.78 | POLB (0.62) | POLBALDH1A1TSHRHDAC6MAPK1 | |
| SCHEMBL2739054 | 0.78 | ALDH1A1 (0.59) | POLBSMN1; SMN2ALDH1A1TSHRHDAC6 | |
| SCHEMBL13798271 | 0.77 | TSHR (0.45) | POLBSMN1; SMN2ALDH1A1TSHRHDAC6 | |
| SCHEMBL12874013 | 0.77 | ALDH1A1 (0.47) | POLBSMN1; SMN2ALDH1A1TSHRUSP2 | |
| SCHEMBL3611548 | 0.77 | TSHR (0.49) | POLBSMN1; SMN2ALDH1A1TSHRHDAC6 | |
| SCHEMBL365996 | 0.77 | TSHR (0.49) | POLBSMN1; SMN2ALDH1A1TSHRHDAC6 | |
| SCHEMBL1984161 | 0.77 | ALDH1A1 (0.43) | POLBSMN1; SMN2ALDH1A1TSHRUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773078-B2 | Furin inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-10-03 | — | — | US | disclosed |
| CN-105431149-B | Neuroprotective multifunctional antioxidants and their monofunctional analogs | 彼得·F·卡罗 | 2019-06-11 | — | — | CN | disclosed |
| EP-2956140-B1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | KADOR PETER F (US) | 2018-07-11 | — | — | EP | disclosed |
| EP-2956140-B1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | KADOR PETER F (US) | 2018-07-11 | — | — | EP | disclosed |
| US-9994552-B2 | Compositions useful for treating disorders related to kit | BLUEPRINT MEDICINES CORPORATION (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170029409-A1 | COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT | BLUEPRINT MEDICINES CORPORATION | 2017-02-02 | — | — | US | disclosed |
| US-9499522-B2 | Compositions useful for treating disorders related to kit | BLUEPRINT MEDICINES CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| CN-105431149-A | Neuroprotective multifunctional antioxidants and their monofunctional analogs | KADOR PETER F | 2016-03-23 | — | — | CN | disclosed |
| EP-2956140-A1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | Kador, Peter F. (US) | 2015-12-23 | — | — | EP | disclosed |
| US-8877766-B2 | Neuroprotective multifunctional antioxidants and their monofunctional analogs | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2014-11-04 | — | — | US | disclosed |
| WO-2014126596-A1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | KADOR PETER F (US) | 2014-08-21 | — | — | WO | disclosed |
| US-20140235858-A1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2014-08-21 | — | — | US | disclosed |
| US-20140235858-A1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2014-08-21 | — | — | US | disclosed |
| US-8592629-B2 | Sulfonamide derivatives as Nav 1.7 inhibitors | PFIZER LIMITED (GB) | 2013-11-26 | — | — | US | disclosed |
| EP-2593432-A1 | N-SULFONYLBENZAMIDE DERIVATIVES USEFUL AS VOLTAGE GATED SODIUM CHANNEL INHIBITORS | Pfizer Limited (GB) | 2013-05-22 | — | — | EP | disclosed |
| WO-2012007861-A1 | N-SULFONYLBENZAMIDE DERIVATIVES USEFUL AS VOLTAGE GATED SODIUM CHANNEL INHIBITORS | PFIZER LIMITED (GB) | 2012-01-19 | — | — | WO | disclosed |
| WO-2012007861-A1 | N-SULFONYLBENZAMIDE DERIVATIVES USEFUL AS VOLTAGE GATED SODIUM CHANNEL INHIBITORS | PFIZER LIMITED (GB) | 2012-01-19 | — | — | WO | disclosed |
| US-20120010183-A1 | Chemical Compounds | PFIZER LIMITED (GB) | 2012-01-12 | — | — | US | disclosed |
| US-20120010183-A1 | Chemical Compounds | PFIZER LIMITED (GB) | 2012-01-12 | — | — | US | disclosed |
| US-20120010183-A1 | Chemical Compounds | PFIZER LIMITED (GB) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010183-A1 | Chemical Compounds | SCN1A, SCN1B, SCN7A | POLB 4442/4885SMN1; SMN2 595/4885ALDH1A1 1098/4885 |
| US-20170029409-A1 | COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT | KIT, APC, CKMT1A; CKMT1B | POLB 231/4885SMN1; SMN2 194/4885ALDH1A1 629/4885 |
| US-11773078-B2 | Furin inhibitors | FURIN, TGFB1, PCSK7 | POLB 2731/4885SMN1; SMN2 2206/4885ALDH1A1 3733/4885 |
| US-20140235858-A1 | NEUROPROTECTIVE MULTIFUNCTIONAL ANTIOXIDANTS AND THEIR MONOFUNCTIONAL ANALOGS | SOD1, SOD3, NFE2L2 | POLB 625/4885SMN1; SMN2 282/4885ALDH1A1 309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.